Hep C Flashcards
How is Hep A transmitted?
Fecal-oral route -person to person and contamination of water
What can you admister as post exposure prophylaxis for a patient infected with Hep A?
Immune globulin (IG) within 2 weeks- stimulates the immune system to recognize the virus
Havrix
MOA- Inactivation Hep A vaccine, inducing the production of specific anti-HAV antibodies
IM Injection
WARNINGS- Latex allergy, bleeding disorder
Monior- LFT, serum neutralizing antibody to Hep A virus (HAVAB and HAVAB-M RIA)
Dosage- adults- 1ml followed by 1ml booster (6-12 months later)
Children- 0.5ml followed by 0.5 ml booster (6-12 months later)
Vaqta
MOA- Inactivation Hep A vaccine, inducing the production of specific anti-HAV antibodies
IM Injection
WARNINGS- Latex allergy, bleeding disorder
Monior- LFT, serum neutralizing antibody to Hep A virus (HAVAB and HAVAB-M RIA)
Dosage- adults- 1ml followed by 1ml booster (6-18 months later)
Children- 0.5ml followed by 0.5 ml booster (6-18 months later)
How old do you need to be to get the Hep A vaccine
at least 12 months for either havrix or Vaqta
How is Hep B tramsmitted?
Blood, Brith and Boinking
unportected sex
mutiple partners
Hep C medication can reactivate Hep B
Which antiviral meications can treat HBV?
Entacavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Engerix B
3 dose series vaciines for Hep B
MOA- recombinant DNA hepatitis B vaccine whihc contains purified surface antigen for the hepatitis B virus
IM injection
WARNING- syncope, apnea in premature infants, dimished immune response in immunoconpromised patients, latex allergy
Monitor- Hep B surface antibody levels
Adminstration schedule- adults 20 years and older (1ml 0,1,6 months) adults on hemodialysis 2ml (0,1,2,6 months)
Heplisav-B
2 dose series for Hep B
MOA- purified HBV surface antigen (hBsAg) with an adjuvant and is used to increase antibody concentrations against HBsAg inorder to confer protection against all known subtypes of hep b virus infections for patients 18 years and older
IM injection
2 dosees 1 month apart
ADR- cell-mediated immune reaction
Monitor- Hep B surface antibody levels
Recomivax
3 dose series vaciines for Hep B
MOA- recombinant DNA hepatitis B vaccine whihc contains purified surface antigen for the hepatitis B virus
IM injection
WARNING- latex allergy, apnea in premature infants, concomitant administration with immune globulin
Monitor- Hep B surface antibody levels
Adults- 3 dose (0, 1, 6 months)
Twinrix
Hep A and Hep B vaccination
MOA- contians inactivated Hep A virus and purified HBsAg that confers active immunity against infectins caused by Hep A virus and all known Hep B virus suntypes
Adminsitration
- Standard- 3 doses (1ml) IM injection at 0, 1, 6 months
- Accelerated- 4 doeses (1ml) IM injection (days 0, 7, 21-30, follwed by a booster dose at 12 months)
Monitoring- rise in anti- HAV at least 20 mIU/mL and anti-HBa levels at 1 mlIU. ML
How is Hep C transmitted?
Blood- blood transfusions, organ trasnplant, sharing needles
Vertical transmission- mother to baby
Sexual contact
NO VACCINE AVAILABLE
What is the goal of Hep C therapy and who should get it?
Reduce mortality rates and preven progression of any other liver-related health conditions by achieving sustained virologic respsone (SVR)
Recommeded for all patients- initiate treatment in all patients with HCV infections
EXCEPT- patients with a short life expectancy, cannot tolerate HCV therapy, longer 15-20 year survival rate when unntreated
Sofobuvir
NS5B Polymerase Inhibitor
MOA- binds to active site to prevent RNA chain so no replication. Enzyme that incorporated neucloside/ nucleotide analog into RNA chain
Grazoprevir
NS3/4A Protease Inhibitor
MOA- C encodes for capsid and E1/E2 encode for envelop. Protease inhibited so virus cannot cleave proteins (non functional) cleaves non structural polyproteins that are utilized in HCV RNA replication
Glecaprevir
NS3/4A Protease Inhibitor
MOA- C encodes for capsid and E1/E2 encode for envelop. Protease inhibited so virus cannot cleave proteins (non functional) cleaves non structural polyproteins that are utilized in HCV RNA replication
Paritaprevir
NS3/4A Protease Inhibitor
MOA- C encodes for capsid and E1/E2 encode for envelop. Protease inhibited so virus cannot cleave proteins (non functional) cleaves non structural polyproteins that are utilized in HCV RNA replication
Simeprevir
NS3/4A Protease Inhibitor
MOA- C encodes for capsid and E1/E2 encode for envelop. Protease inhibited so virus cannot cleave proteins (non functional) cleaves non structural polyproteins that are utilized in HCV RNA replication
Voxilaprevir
NS3/4A Protease Inhibitor
MOA- C encodes for capsid and E1/E2 encode for envelop. Protease inhibited so virus cannot cleave proteins (non functional) cleaves non structural polyproteins that are utilized in HCV RNA replication